GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » 3-Year EBITDA Growth Rate

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) 3-Year EBITDA Growth Rate : 22.80% (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co 3-Year EBITDA Growth Rate?

Shenzhen New Industries Biomedical Engineering Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.63.

During the past 12 months, Shenzhen New Industries Biomedical Engineering Co's average EBITDA Per Share Growth Rate was 6.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 22.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 18.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shenzhen New Industries Biomedical Engineering Co was 41.80% per year. The lowest was -1.10% per year. And the median was 20.90% per year.


Competitive Comparison of Shenzhen New Industries Biomedical Engineering Co's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Shenzhen New Industries Biomedical Engineering Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen New Industries Biomedical Engineering Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen New Industries Biomedical Engineering Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shenzhen New Industries Biomedical Engineering Co's 3-Year EBITDA Growth Rate falls into.


;
;

Shenzhen New Industries Biomedical Engineering Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Shenzhen New Industries Biomedical Engineering Co  (SZSE:300832) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Shenzhen New Industries Biomedical Engineering Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen New Industries Biomedical Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518118
Shenzhen New Industries Biomedical Engineering Co Ltd is researching, developing, producing and selling a series of fully automatic chemiluminescence immunoassay instruments and supporting reagents.
Executives
Rao Jie Director
Liu Hai Yan Executives
Ma Jie Supervisors
Ding Chen Liu Executives
Zhang Xiao Hong Executives
Zhang Lei Directors, executives
Li Ting Hua Executives
Song Hong Tao Supervisors
Liu Peng Director
Jiang Li Li Supervisors

Shenzhen New Industries Biomedical Engineering Co Headlines

No Headlines